assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001687805.1_ASM168780v1	NZ_CP016414	Vibrio scophthalmi strain VS-05 chromosome 1, complete sequence	1	1687669-1687744	1	CRISPRCasFinder	no		DEDDh,DinG,cas3,RT,csx1,csa3	Orphan	AAAAGCAAAAGCGAGATTCCCTT	23	0	0	NA	NA	NA	1	1	Orphan	DEDDh,DinG,cas3,RT,csx1,csa3,WYL	NA|195aa|up_5|NZ_CP016414.1_1681074_1681659_-,NA|117aa|up_4|NZ_CP016414.1_1681684_1682035_-,NA|81aa|up_2|NZ_CP016414.1_1683544_1683787_+,NA|113aa|up_0|NZ_CP016414.1_1687108_1687447_-,NA|237aa|down_0|NZ_CP016414.1_1688388_1689099_+	NA|333aa|up_9|NZ_CP016414.1_1677272_1678271_-	pfam13515, FUSC_2, Fusaric acid resistance protein-like	NA|194aa|up_8|NZ_CP016414.1_1678445_1679027_-	COG2249, MdaB, Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]	NA|117aa|up_7|NZ_CP016414.1_1679089_1679440_-	cd04769, HTH_MerR2, Helix-Turn-Helix DNA binding domain of MerR2-like transcription regulators	NA|429aa|up_6|NZ_CP016414.1_1679655_1680942_+	COG0513, SrmB, Superfamily II DNA and RNA helicases [DNA replication, recombination, and repair / Transcription / Translation, ribosomal structure and biogenesis]	NA|195aa|up_5|NZ_CP016414.1_1681074_1681659_-	NA	NA|117aa|up_4|NZ_CP016414.1_1681684_1682035_-	NA	NA|342aa|up_3|NZ_CP016414.1_1682332_1683358_+	cd00997, PBP2_GluR0, Bacterial GluR0 ligand-binding domain; the type 2 periplasmic binding protein fold	NA|81aa|up_2|NZ_CP016414.1_1683544_1683787_+	NA	NA|165aa|up_1|NZ_CP016414.1_1683903_1684398_+	pfam14317, YcxB, YcxB-like protein	NA|113aa|up_0|NZ_CP016414.1_1687108_1687447_-	NA	NA|237aa|down_0|NZ_CP016414.1_1688388_1689099_+	NA	NA|297aa|down_1|NZ_CP016414.1_1689224_1690115_-	pfam13306, LRR_5, Leucine rich repeats (6 copies)	NA|403aa|down_2|NZ_CP016414.1_1690283_1691492_+	pfam01609, DDE_Tnp_1, Transposase DDE domain	NA|393aa|down_3|NZ_CP016414.1_1692024_1693203_-	TIGR02421, conserved_hypothetical_protein, conserved hypothetical protein	NA|245aa|down_4|NZ_CP016414.1_1693525_1694260_+	cd18109, SpoU-like_RNA-MTase, SAM-dependent RNA methylase related to SpoU-TrmH	NA|108aa|down_5|NZ_CP016414.1_1694386_1694710_-	pfam11953, DUF3470, Domain of unknown function (DUF3470)	NA|539aa|down_6|NZ_CP016414.1_1694952_1696569_+	COG2509, COG2509, Uncharacterized FAD-dependent dehydrogenases [General function prediction only]	NA|167aa|down_7|NZ_CP016414.1_1696749_1697250_+	pfam04664, OGFr_N, Opioid growth factor receptor (OGFr) conserved region	NA|195aa|down_8|NZ_CP016414.1_1697485_1698070_+	sd00006, TPR, Tetratricopeptide repeat	NA|168aa|down_9|NZ_CP016414.1_1698277_1698781_+	PRK12846, PRK12846, peptide deformylase; Reviewed
